Skip to main content
. 2021 Jun 14;11:12454. doi: 10.1038/s41598-021-91870-4

Figure 2.

Figure 2

Example of FACS analysis of the PBMC proliferation assay using the FL-1 channel (a) PBMC proliferation assay using fMSC (i) control unstimulated fPBMC, (ii) control activated fPBMC, (iii) activated fPBMC + primedc fMSC donor 1, (iv) activated fPBMC + primed fMSC donor 2, (v) activated fPBMC + primed fMSC donor 3, (vi) activated fPBMC + primed fMSC donor 4 compared to (b) PBMC assay using mMSC (i) control unstimulated fPBMC, (ii) control activated fPBMC, (iii) activated fPBMC + primed mMSC donor 1, (iv) activated fPBMC + primed mMSC donor 2, (v) activated fPBMC + primed mMSC donor 3, (vi) activated fPBMC + primed mMSC donor 4. (c) Individual MSC mediated immune suppression of both male and female PBMC expressed as a percentage indicatiing the suppression rate and (d)suppression (mean ± SEM) of fPBMC (n = 3) and mPBMC (n = 3) against both fMSC (n = 4) and mMSC (n = 4).